Cargando…

Acceptability and Feasibility of Repeated Mucosal Specimen Collection in Clinical Trial Participants in Kenya

BACKGROUND: Mucosal specimens are essential to evaluate compartmentalized immune responses to HIV vaccine candidates and other mucosally targeted investigational products. We studied the acceptability and feasibility of repeated mucosal sampling in East African clinical trial participants at low ris...

Descripción completa

Detalles Bibliográficos
Autores principales: Omosa-Manyonyi, Gloria, Park, Harriet, Mutua, Gaudensia, Farah, Bashir, Bergin, Philip J., Laufer, Dagna, Lehrman, Jennifer, Chinyenze, Kundai, Barin, Burc, Fast, Pat, Gilmour, Jill, Anzala, Omu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2014
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4215886/
https://www.ncbi.nlm.nih.gov/pubmed/25360819
http://dx.doi.org/10.1371/journal.pone.0110228
_version_ 1782342170147028992
author Omosa-Manyonyi, Gloria
Park, Harriet
Mutua, Gaudensia
Farah, Bashir
Bergin, Philip J.
Laufer, Dagna
Lehrman, Jennifer
Chinyenze, Kundai
Barin, Burc
Fast, Pat
Gilmour, Jill
Anzala, Omu
author_facet Omosa-Manyonyi, Gloria
Park, Harriet
Mutua, Gaudensia
Farah, Bashir
Bergin, Philip J.
Laufer, Dagna
Lehrman, Jennifer
Chinyenze, Kundai
Barin, Burc
Fast, Pat
Gilmour, Jill
Anzala, Omu
author_sort Omosa-Manyonyi, Gloria
collection PubMed
description BACKGROUND: Mucosal specimens are essential to evaluate compartmentalized immune responses to HIV vaccine candidates and other mucosally targeted investigational products. We studied the acceptability and feasibility of repeated mucosal sampling in East African clinical trial participants at low risk of HIV and other sexually transmitted infections. METHODS AND FINDINGS: The Kenya AIDS Vaccine Initiative (KAVI) enrolled participants into three Phase 1 trials of preventive HIV candidate vaccines in 2011–2012 at two clinical research centers in Nairobi. After informed consent to a mucosal sub-study, participants were asked to undergo collection of mucosal secretions (saliva, oral fluids, semen, cervico-vaginal and rectal), but could opt out of any collection at any visit. Specimens were collected at baseline and two additional time points. A tolerability questionnaire was administered at the final sub-study visit. Of 105 trial participants, 27 of 34 women (79%) and 62 of 71 men (87%) enrolled in the mucosal sub-study. Nearly all sub-study participants gave saliva and oral fluids at all visits. Semen was collected from about half the participating men (47–48%) at all visits. Cervico-vaginal secretions were collected by Softcup from about two thirds of women (63%) at baseline, increasing to 78% at the following visits, with similar numbers for cervical secretion collection by Merocel sponge; about half of women (52%) gave cervico-vaginal samples at all visits. Rectal secretions were collected with Merocel sponge from about a quarter of both men and women (24%) at all 3 visits, with 16% of men and 19% of women giving rectal samples at all visits. CONCLUSIONS: Repeated mucosal sampling in clinical trial participants in Kenya is feasible, with a good proportion of participants consenting to most sampling methods with the exception of rectal samples. Experienced staff members of both sexes and trained counselors with standardized messaging may improve acceptance of rectal sampling.
format Online
Article
Text
id pubmed-4215886
institution National Center for Biotechnology Information
language English
publishDate 2014
publisher Public Library of Science
record_format MEDLINE/PubMed
spelling pubmed-42158862014-11-05 Acceptability and Feasibility of Repeated Mucosal Specimen Collection in Clinical Trial Participants in Kenya Omosa-Manyonyi, Gloria Park, Harriet Mutua, Gaudensia Farah, Bashir Bergin, Philip J. Laufer, Dagna Lehrman, Jennifer Chinyenze, Kundai Barin, Burc Fast, Pat Gilmour, Jill Anzala, Omu PLoS One Research Article BACKGROUND: Mucosal specimens are essential to evaluate compartmentalized immune responses to HIV vaccine candidates and other mucosally targeted investigational products. We studied the acceptability and feasibility of repeated mucosal sampling in East African clinical trial participants at low risk of HIV and other sexually transmitted infections. METHODS AND FINDINGS: The Kenya AIDS Vaccine Initiative (KAVI) enrolled participants into three Phase 1 trials of preventive HIV candidate vaccines in 2011–2012 at two clinical research centers in Nairobi. After informed consent to a mucosal sub-study, participants were asked to undergo collection of mucosal secretions (saliva, oral fluids, semen, cervico-vaginal and rectal), but could opt out of any collection at any visit. Specimens were collected at baseline and two additional time points. A tolerability questionnaire was administered at the final sub-study visit. Of 105 trial participants, 27 of 34 women (79%) and 62 of 71 men (87%) enrolled in the mucosal sub-study. Nearly all sub-study participants gave saliva and oral fluids at all visits. Semen was collected from about half the participating men (47–48%) at all visits. Cervico-vaginal secretions were collected by Softcup from about two thirds of women (63%) at baseline, increasing to 78% at the following visits, with similar numbers for cervical secretion collection by Merocel sponge; about half of women (52%) gave cervico-vaginal samples at all visits. Rectal secretions were collected with Merocel sponge from about a quarter of both men and women (24%) at all 3 visits, with 16% of men and 19% of women giving rectal samples at all visits. CONCLUSIONS: Repeated mucosal sampling in clinical trial participants in Kenya is feasible, with a good proportion of participants consenting to most sampling methods with the exception of rectal samples. Experienced staff members of both sexes and trained counselors with standardized messaging may improve acceptance of rectal sampling. Public Library of Science 2014-10-31 /pmc/articles/PMC4215886/ /pubmed/25360819 http://dx.doi.org/10.1371/journal.pone.0110228 Text en © 2014 Omosa-Manyonyi et al http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are properly credited.
spellingShingle Research Article
Omosa-Manyonyi, Gloria
Park, Harriet
Mutua, Gaudensia
Farah, Bashir
Bergin, Philip J.
Laufer, Dagna
Lehrman, Jennifer
Chinyenze, Kundai
Barin, Burc
Fast, Pat
Gilmour, Jill
Anzala, Omu
Acceptability and Feasibility of Repeated Mucosal Specimen Collection in Clinical Trial Participants in Kenya
title Acceptability and Feasibility of Repeated Mucosal Specimen Collection in Clinical Trial Participants in Kenya
title_full Acceptability and Feasibility of Repeated Mucosal Specimen Collection in Clinical Trial Participants in Kenya
title_fullStr Acceptability and Feasibility of Repeated Mucosal Specimen Collection in Clinical Trial Participants in Kenya
title_full_unstemmed Acceptability and Feasibility of Repeated Mucosal Specimen Collection in Clinical Trial Participants in Kenya
title_short Acceptability and Feasibility of Repeated Mucosal Specimen Collection in Clinical Trial Participants in Kenya
title_sort acceptability and feasibility of repeated mucosal specimen collection in clinical trial participants in kenya
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4215886/
https://www.ncbi.nlm.nih.gov/pubmed/25360819
http://dx.doi.org/10.1371/journal.pone.0110228
work_keys_str_mv AT omosamanyonyigloria acceptabilityandfeasibilityofrepeatedmucosalspecimencollectioninclinicaltrialparticipantsinkenya
AT parkharriet acceptabilityandfeasibilityofrepeatedmucosalspecimencollectioninclinicaltrialparticipantsinkenya
AT mutuagaudensia acceptabilityandfeasibilityofrepeatedmucosalspecimencollectioninclinicaltrialparticipantsinkenya
AT farahbashir acceptabilityandfeasibilityofrepeatedmucosalspecimencollectioninclinicaltrialparticipantsinkenya
AT berginphilipj acceptabilityandfeasibilityofrepeatedmucosalspecimencollectioninclinicaltrialparticipantsinkenya
AT lauferdagna acceptabilityandfeasibilityofrepeatedmucosalspecimencollectioninclinicaltrialparticipantsinkenya
AT lehrmanjennifer acceptabilityandfeasibilityofrepeatedmucosalspecimencollectioninclinicaltrialparticipantsinkenya
AT chinyenzekundai acceptabilityandfeasibilityofrepeatedmucosalspecimencollectioninclinicaltrialparticipantsinkenya
AT barinburc acceptabilityandfeasibilityofrepeatedmucosalspecimencollectioninclinicaltrialparticipantsinkenya
AT fastpat acceptabilityandfeasibilityofrepeatedmucosalspecimencollectioninclinicaltrialparticipantsinkenya
AT gilmourjill acceptabilityandfeasibilityofrepeatedmucosalspecimencollectioninclinicaltrialparticipantsinkenya
AT anzalaomu acceptabilityandfeasibilityofrepeatedmucosalspecimencollectioninclinicaltrialparticipantsinkenya